Adicet Bio, Inc. (ACET)
NASDAQ: ACET · Real-Time Price · USD
7.29
+0.04 (0.55%)
Mar 2, 2026, 4:00 PM EST - Market closed
Adicet Bio Market Cap
Adicet Bio has a market cap or net worth of $73.67 million as of March 3, 2026. Its market cap has decreased by -9.84% in one year.
Market Cap
73.67M
Enterprise Value
-13.89M
1-Year Change
-9.84%
Ranking
Category
Stock Price
$7.29
Market Cap Chart
Since September 16, 2020, Adicet Bio's market cap has decreased from $301.68M to $73.67M, a decrease of -75.58%. That is a compound annual growth rate of -22.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 73.67M | -13.42% |
| Dec 31, 2025 | 85.10M | -2.63% |
| Dec 31, 2024 | 87.39M | 7.13% |
| Dec 29, 2023 | 81.58M | -78.70% |
| Dec 30, 2022 | 383.09M | -44.04% |
| Dec 31, 2021 | 684.61M | 148.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pliant Therapeutics | 79.88M |
| Seres Therapeutics | 79.07M |
| eXoZymes | 74.34M |
| Fractyl Health | 71.98M |
| ImageneBio | 71.57M |
| MediciNova | 71.37M |
| Annovis Bio | 71.03M |
| XBiotech | 68.90M |